Ya-Jui Lin
Overview
Explore the profile of Ya-Jui Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu C, Chen Y, Lin Y, Wei K, Chang K, Feng L, et al.
Cancer Res
. 2024 Dec;
84(23):4017-4030.
PMID: 39618248
Glioblastoma (GBM) is a highly aggressive brain tumor with poor prognosis and high recurrence rates. The complex immune microenvironment of GBM is highly infiltrated by tumor-associated microglia and macrophages (TAM)....
2.
Nien J, Chuang C, Hsu P, Huang Y, Tsai H, Chen P, et al.
Clin Neurol Neurosurg
. 2024 Sep;
246:108551.
PMID: 39288687
Purpose: The role of tumor resection remains undetermined in treating primary central nervous system lymphomas (PCNSLs). This study aimed to clarify the impact of tumor resection on survival and functional...
3.
Huang C, Li J, Chen K, Lin Y, Feng L, Liu H, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254744
Sonodynamic therapy (SDT) is a novel tumor treatment that combines biosafe sonosensitizers and noninvasive focused ultrasound to eradicate solid tumors. Sonosensitizers such as 5-aminolevulinic acid and fluorescein have great potential...
4.
Yi-Feng Chang I, Tsai H, Chen C, Chen H, Huang C, Cox G, et al.
Biomed J
. 2023 Sep;
47(4):100660.
PMID: 37741340
Background: A previous phase 1 dose-escalation study in Taiwan indicated CAN008 (asunercept) with standard concurrent chemoradiotherapy (CCRT) improved progression-free survival (PFS) in newly diagnosed glioblastoma (GBM) patients. This study evaluates...
5.
Tsai H, Tong Z, Hwang T, Wei K, Chen P, Huang C, et al.
Free Radic Biol Med
. 2023 Jul;
207:17-28.
PMID: 37414347
Acrolein, which is the most reactive aldehyde, is a byproduct of lipid peroxidation in a hypoxic environment. Acrolein has been shown to form acrolein-cysteine bonds, resulting in functional changes in...
6.
Yeh Y, Lin Y, Yeh C, Hsieh P, Wu C
J Neurosurg Case Lessons
. 2022 Jul;
1(20):CASE20159.
PMID: 35855020
Background: Marfan syndrome is rarely accompanied by anterior sacral meningocele (ASM) resulting from erosion of the sacrum by dural ectasia. ASM may induce symptoms due to severe mass effects. ASM...
7.
Li Y, Chiu H, Wei K, Lin Y, Chen K, Hsu P, et al.
Biomed J
. 2022 Jun;
44(6 Suppl 1):S48-S53.
PMID: 35735084
Background: Awake craniotomy is an effective method by which to reduce postoperative neurologic deficit in newly-diagnosed glioma patients. However, the level of functional preservation in patients undergoing resection of recurrent...
8.
Lin Y, Wu C, Wu J, Lim M
Front Immunol
. 2022 Jun;
13:887781.
PMID: 35711434
Gliomas are intrinsic brain tumors that originate from glial cells. Glioblastoma (GBM) is the most aggressive glioma type and resistant to immunotherapy, mainly due to its unique immune environment. Dimensional...
9.
Liu P, Li Y, Zhang Y, Choi J, Zhang J, Shang G, et al.
Front Oncol
. 2022 Jun;
12:708272.
PMID: 35646664
Gliomas are the most common primary brain cancer. While it has been known that calcium-related genes correlate with gliomagenesis, the relationship between calcium-related genes and glioma prognosis remains unclear. We...
10.
Li Y, Chen C, Chen C, Tu P, Yeap M, Wu Y, et al.
Front Surg
. 2022 May;
9:852576.
PMID: 35586508
Objective: Delayed progressive mass effect (DPME) after securing an aneurysm is uncommon following microsurgical or endovascular repair and leads to a poor clinical outcome. Patients with ruptured middle cerebral artery...